These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23971129)

  • 1. [Head and neck cancer].
    Inohara H
    Gan To Kagaku Ryoho; 2013 Jul; 40(7):851. PubMed ID: 23971129
    [No Abstract]   [Full Text] [Related]  

  • 2. Can molecular markers predict local, regional and distant metastasis in head and neck cancer?
    Haffty BG
    Nat Clin Pract Oncol; 2005 Mar; 2(3):132-3. PubMed ID: 16264904
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical applications of DNA content parameters in patients with squamous cell carcinomas of the head and neck.
    Ensley JF; Maciorowski Z
    Semin Oncol; 1994 Jun; 21(3):330-9. PubMed ID: 8209264
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene expression profiling in head and neck squamous cell carcinoma: Clinical perspectives.
    Lallemant B; Evrard A; Chambon G; Sabra O; Kacha S; Lallemant JG; Lumbroso S; Brouillet JP
    Head Neck; 2010 Dec; 32(12):1712-9. PubMed ID: 20949446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Head and neck cancer].
    Tukuda M
    Gan To Kagaku Ryoho; 2008 Jul; 35(7):1105. PubMed ID: 18686356
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment of fixed and semi-fixed cervical metastases in head and neck cancer.
    Martins AS
    Rev Paul Med; 1993; 111(4):27-32. PubMed ID: 8108643
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of metastases in cancer of the head and neck. Behavior of cervical lymph nodes of pharyngeal carcinoma.
    Pinto JA
    Rev Paul Med; 1993; 111(4):21-6. PubMed ID: 8108642
    [No Abstract]   [Full Text] [Related]  

  • 8. Head and neck cancer: reduce and integrate for optimal outcome.
    Belbin TJ; Bergman A; Brandwein-Gensler M; Chen Q; Childs G; Garg M; Haigentz M; Hogue-Angeletti R; Moadel R; Negassa A; Owen R; Prystowsky MB; Schiff B; Schlecht NF; Shifteh K; Smith RV; Zheng X
    Cytogenet Genome Res; 2007; 118(2-4):92-109. PubMed ID: 18000360
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic value of the anatomopathologic variables in head and neck cancer.
    Saba LM
    Rev Paul Med; 1993; 111(4):8-10. PubMed ID: 8108653
    [No Abstract]   [Full Text] [Related]  

  • 10. Head and neck cancer emerging strategies: advances and new challenges.
    Awada A; de Castro G
    Curr Opin Oncol; 2009 May; 21(3):191-3. PubMed ID: 19346942
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular pathogenesis of head and neck cancers.
    Singh B
    J Surg Oncol; 2008 Jun; 97(8):634-9. PubMed ID: 18493941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How will increasing our knowledge of the head and neck cancer cells' secretome benefit head and neck squamous cell carcinoma patients?
    Ralhan R
    Expert Rev Proteomics; 2012 Apr; 9(2):115-8. PubMed ID: 22462781
    [No Abstract]   [Full Text] [Related]  

  • 13. Cervical lymphatics and squamous cell carcinoma of the head and neck: biologic significance and therapeutic considerations.
    Carlson GW
    Surg Oncol Clin N Am; 1996 Jan; 5(1):65-77. PubMed ID: 8789494
    [No Abstract]   [Full Text] [Related]  

  • 14. Current role of gene therapy in head and neck cancer.
    Ganly I; Soutar DS; Kaye SB
    Eur J Surg Oncol; 2000 Jun; 26(4):338-43. PubMed ID: 10873352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selecting patients for planned neck dissection after chemoradiotherapy in regionally advanced head and neck cancer.
    Agarwal JP; Mallick I; Ghosh-Laskar S; Gupta T; Budrukkar A; Murthy V
    Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1121-2; author reply 1122. PubMed ID: 18936367
    [No Abstract]   [Full Text] [Related]  

  • 16. Current considerations in multimodality therapy of head and neck cancer.
    Sloan DA; McGrath PC; Kenady DE
    Clin Plast Surg; 1995 Jan; 22(1):9-19. PubMed ID: 7743713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent treatment modality for advanced head and neck carcinomas].
    Tsukuda M
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1657-64. PubMed ID: 9757189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of VEGF and inhibition of tumor angiogenesis by abrogation of VEGF in head and neck cancer].
    Riedel F
    Laryngorhinootologie; 2003 Jun; 82(6):436-7. PubMed ID: 12851852
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic significance of P53 histochemistry and DNA histogram parameters in head and neck malignancies.
    Tamás L; Kraxner H; Mechtler L; Répássy G; Ribári O; Hirschberg A; Szentkúti G; Járay B; Szentirmay Z
    Anticancer Res; 2000; 20(5C):4031-7. PubMed ID: 11268497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalizing cancer care: updates on head and neck cancer.
    de Souza JA; Cohen EE
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1219-22. PubMed ID: 19761425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.